Johnson & Johnson (JNJ) Stock Near Record Highs: What to Know Before the Market Opens on December 8, 2025
Published: December 7, 2025 – ahead of Monday’s U.S. market open Johnson & Johnson (NYSE: JNJ) heads into Monday’s session sitting just below its 52‑week high, with fresh drug data, new access to the Chinese market and ongoing talc litigation all pulling on the share price at once. After an almost year‑long rally of roughly 40% in 2025, investors now have to decide whether JNJ is a defensive dividend giant that still has room to run — or a blue‑chip that’s priced for perfection going into 2026. Simply Wall St+1 Below is a fast pre‑market briefing based on the newest